Randomized phase I trial of adjuvant individualized TG4050 vaccine in patients with locally advanced resected HPV-negative head and neck squamous cell carcinoma (HNSCC)

C. Le Tourneau, et al.

SITC 2024 

Abstract disponible sur le site du SITC – Télécharger abstract and the poster